Prevalence of human papillomavirus (HPV) and HPV-16 genotyping by real-time PCR in patients with several cervical pathologies

Brazilian Journal of Infectious Diseases

Volumn 14, Issue 1, 2010, Pages 19-23

  Dinc, Bedia ^a   Rota, Seyyal ^a   Onan, Anil ^a   Bozdayi, Gulendam ^a   Taskiran, Cagatay ^b   Biri, Aydan ^b   Guner, Haldun ^b  

^a Medical Biology and Genetic Department Medicine Faculty   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Colposcopy; HPV type 16; Real time PCR

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COLPOSCOPY; CONTROLLED STUDY; DNA PROBE; FALSE POSITIVE RESULT; FEMALE; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; PARITY; REAL TIME POLYMERASE CHAIN REACTION; SEXUAL INTERCOURSE; UTERINE CERVIX DISEASE; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

EID: 77954778697     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1413-86702010000100005     Document Type: Article

References (32)

1. Monk BJ, Herzog TJ. The new era of cervical cancer prevention: HPV vaccination. Gynecol Oncol 2008; 109 (2 Suppl):S1-3.
2. Benedet JL. Progress in gynecologic cancer detection and treatment. International Journal of Gynecology and Obstetrics 2000; 70:135-47.
3. Spinillo A, Debiaggi M, Zara F et al. Human Immunodeficiency Virus Type 1- Related Nucleic Acids and Papillomavirus DNA in Cervicovaginal Secretions of Immunodeficiency Virus- Infected Women. Obstetrics and Gynecology 2001; 97:999-1004.
4. Matos E, Loria D, Amestoy GM et al. Prevalance of Human Papillomavirus Infection Among Women in Concordia, Argentina: A Population-Based Study. Sexually Transmitted Diseases 2003; 27:593-9.
5. Moberg M, Gustavsson I, Gyllensten U. Real-Time PCR-Based System for Simultaneous Quantification of Human Papillomavirus Types Associated with High Risk of Cervical Cancer. Journal of Clinical Microbiology 2003; 41:3221-8.
6. Franco EL, Duarte- Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ 2001; 164:1017-25.
7. Perrons C, Kleter B, Jelley R et al. Detection and Genotyping of Human Papillomavirus DNA by SPF10 and MY09/11 Primers in Cervical Cells Taken From Women Attending a Colposcopy Clinic. Journal of Medical Virology 2002; 67:246-52.
8. Severson J, Evans T, Lee P et al. Human Papillomavirus Infections: Epidemiology, Pathogenesis, and Therapy. Journal of Cutaneous Medicine and Surgery 2001; 5: 43-60.
9. Mayeaux EJ. Reducing the economic burden of HPV-related diseases. J Am Osteopath Assoc 2008; 108 (4 Suppl 2):52-7.
10. Tuncer S, Ustacelebi S. Detection of Human Papillomavirus Type 16 and 18 by polymerase chain reaction in cervical biopsy samples. Flora 1996; 1:40-4.
11. Onan MA, Taskiran C, Bozdayi G et al. Assessment of human papilloma viral load of archival cervical intraepithelial neoplasia by real-time polymerase chain reaction in a Turkish population. Eur J Gynaecol Oncol 2005; 26(6):632-5.
12. Ozturk S, Kaleli I, Kaleli B, Bir F. Investigation of human papillomavirus DNA in cervical specimens by hybrid capture assay. Mikrobiyol Bul 2004; 38(3):223-32.
13. Oliveira LH, Rosa ML, Pereira CR et al. Human papillomavirus status and cervical abnormalities in women from public and private health care in Rio de Janeiro State, Brazil. Rev Inst Med Trop São Paulo 2006; 48(5):279-85.
14. Dunne EF, Unger ER, Sternberg M et al. Prevalence of HPV infection among females in the United States. JAMA 2007; 297(8):813-9.
15. Ferreccio C, Corvalan A, Margozzini P et al. Baseline assessment of prevalence and geographical distribution of HPV types in Chile using self-collected vaginal samples. BMC Public Health 2008; 8:78.
16. Ko V, Nanji S, Tambouret RH, Wilbur DC. Testing for HPV as an objective measure for quality assurance in gynecologic cytology: positive rates in equivocal and abnormal specimens and comparison with the ASCUS to SIL ratio. Cancer 2007; 111(2):67-73.
17. Sellors JW, Mahony JB, Kaczorowski J et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. CMAJ 2000; 163:503-8.
18. Kahn JA, Rosenthal SL, Succop PA et al. Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection. Pediatrics 2002; 109(1):E5.
19. Flores YN, Bishai DM, Shah KV et al. Risk factors for cervical cancer among HPV positive women in Mexico. Salud Publica Mex. 2008; 50(1):49-58.
20. Castle PE, Wacholder S, Lorincz AT et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst. 2002; 94(18):1406-14
21. Vaccarella S, Herrero R, Dai M et al. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol Biomarkers Prev. 2006; 15(11):2148-53.
22. Shields TS, Brinton LA, Burk RD et al. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus. Cancer Epidemiol Biomarkers Prev. 2004; 13(10):1574-82.
23. Castellsagué X, Díaz M, de Sanjosé S et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst. 2006; 98(5):303-15.
24. Mayrand MH, Duarte-Franco E, Rodrigues I et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007; 357(16):1579-88.
25. Naucler P, Ryd W, Törnberg S et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med. 2007; 357(16):1589-97.
26. Cuzick J. Role of HPV testing in clinical practice. Virus Research. 2002; 89:263-9.
27. Grce M, Husnjak K, Bozikov J et al. Evaluation of Genital Human Papillomavirus Infections by Polymerase Chain Reaction among Croatian Women. Anticancer Research. 2001; 21:579-84.
28. Fife KH, Cramer HM, Schroeder JM, Brown DR. Detection of Multiple Human Papillomavirus Types in the Lower Genital Tract Correlates With Cervical Dysplasia. Journal of Medical Virology. 2001; 64:550-9.
29. Yang YY, Koh LW, Tsai CH et al. Correlation of viral factors with cervical cancer in Taiwan. J Microbiol Immunol Infect. 2004; 37:282-7.
30. Antonishyn NA, Horsman GB, Kelln RA et al. The impact of the distribution of human papillomavirus types and associated high-risk lesions in a colposcopy population for monitoring vaccine efficacy. Arch Pathol Lab Med. 2008; 132(1):54-60.
31. Shah K V, Solomon L, Daniel R et al. Comparison of PCR and Hybrid Capture Methods for Detection of Human Papillomavirus in Injection Drug- Using Women at High Risk of Human Immunodeficiency Virus Infection. Journal of Clinical Microbiology. 1997; 35:517-9.
32. Bryant-Greenwood P. Molecular Diagnostics in Obstetrics and Gynecology. Clinical Obstetrics and Gynecology. 2002; 45:605-21.